Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AVTX
AVTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AVTX News
Avalo Therapeutics to Join Russell Indices
Jun 26 2026
seekingalpha
Avalo Therapeutics Added to Russell 2000 and 3000 Indices
Jun 26 2026
Newsfilter
Avalo Therapeutics Appoints New Board Member
Jun 24 2026
NASDAQ.COM
Avalo Plans IND Submission for AVTX-010 in H1 2027
Jun 16 2026
Newsfilter
Latest Ratings and Outlook from Wall Street
Jun 12 2026
CNBC
Avalo Therapeutics Q1 Earnings Beat Expectations with Strong Cash Position
May 13 2026
seekingalpha
Avalo to Offer 19.73 Million Shares at $17.75 Each
May 06 2026
stocktwits
Avalo Therapeutics Prices Public Offering at $375M
May 06 2026
seekingalpha
Avalo Therapeutics Prices Public Offering at $17.75 per Share
May 06 2026
Newsfilter
Avalo Plans to Advance Abdakibart into Late-Stage Registration
May 05 2026
stocktwits
Avalo Therapeutics Reports FY EPS Beat Despite Revenue Decline
Mar 23 2026
seekingalpha
Avalo Therapeutics Completes Enrollment for AVTX-009 Trial
Feb 02 2026
Benzinga
Valvoline Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations
Dec 18 2025
Benzinga
Avalo Therapeutics Reveals Inducement Grants for New Hires in Accordance with Nasdaq Listing Rule 5635(c)(4)
Nov 17 2025
Newsfilter
Avalo Therapeutics Completes Patient Enrollment in Phase 2 LOTUS Trial for AVTX-009 Targeting Hidradenitis Suppurativa Treatment
Oct 29 2025
Newsfilter
DFAS's Assets May Indicate a 15% Profit Opportunity
Oct 02 2025
NASDAQ.COM
Show More News
